Generex Biotechnology Corporation Subsidiary, Olaregen Therapeutix Announces its Malaysian Distribution Partner, Nexgen Medical, has gained approval for the use of Excellagen® Wound Conforming Matrix from The Malaysian Ministry of Health, its country’s equivalent to the U.S. FDA

MIRAMAR, Fla., July 26, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) subsidiary Olaregen Therapeutix announced in May that the company has executed a Distribution Agreement with Nexgen Medical Sdn Bhd, Inc. (“Nexgen”)...
Generex Investor Call​​Click To Listen
Generex Investor Call​​Click To Listen
Generex Investor Call​​Click To Listen
Generex Investor Call​​Click To Listen
Generex Investor Call​​Click To Listen